DrugPatentWatch Database Preview
RITALIN LA Drug Profile
Which patents cover Ritalin La, and what generic alternatives are available?
Ritalin La is a drug marketed by Novartis and is included in one NDA. There is one patent protecting this drug and two Paragraph IV challenges.
The generic ingredient in RITALIN LA is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
Summary for RITALIN LA
Pharmacology for RITALIN LA
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
Synonyms for RITALIN LA
| 113-45-1 (Parent) |
| 2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester, hydrochloride |
| 2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride |
| 2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride, (R*,R*)-(+-)- |
| 298-59-9 |
| 298M599 |
| AC1L1SQ4 |
| AC1Q5YRN |
| AK116471 |
| AKOS016010356 |
| alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride |
| AN-23356 |
| API0003340 |
| CAS-298-59-9 |
| CC-30903 |
| CCG-213572 |
| CCRIS 6258 |
| Centedrin |
| Centedrine |
| CHEBI:31836 |
| CHEMBL1722 |
| ciba 4311b |
| Concerta (TN) |
| CS-4658 |
| D-erythro-Methylphenidate Hydrochloride |
| D01296 |
| DSSTox_CID_886 |
| DSSTox_GSID_20886 |
| DSSTox_RID_75843 |
| DTXSID8020886 |
| EINECS 206-065-3 |
| FT-0603372 |
| FT-0672046 |
| FT-0672047 |
| H-Tic-OtBu.HCl |
| HE332528 |
| HY-B1091A |
| JUMYIBMBTDDLNG-UHFFFAOYSA-N |
| LS-42 |
| Medikinet |
| Meridil hydrochloride |
| Metadate |
| Metadate (TN) |
| Metadate CD |
| Metadate ER |
| Methyl .alpha.-phenyl-2-piperidineacetate hydrochloride |
| methyl 2-phenyl-2-(2-piperidyl)acetate hydrochloride |
| METHYL 2-PHENYL-2-(PIPERIDIN-2-YL)ACETATE HCL |
| Methyl 2-phenyl-2-(piperidin-2-yl)acetate hydrochloride |
| methyl 2-phenyl-2-piperidin-2-ylacetate hydrochloride |
| methyl alpha-phenyl-2-piperidine-acetate hydrochloride |
| Methyl alpha-phenyl-2-piperidineacetate hydrochloride |
| Methyl Phenidylacetate Hydrochloride |
| methyl phenyl(piperidin-2-yl)acetate hydrochloride |
| Methylin ER |
| Methylphenidan Hydrochloride |
| Methylphenidate (hydrochloride) |
| Methylphenidate HCl |
| METHYLPHENIDATE HYDROCHLORIDE |
| Methylphenidate hydrochloride (JAN/USP) |
| Methylphenidate hydrochloride [USAN:JAN] |
| Methylphenidate hydrochloride [USP:JAN] |
| Methylphenidate Hydrochloride ER |
| Methylphenidate hydrochloride solution, (Racemic mixture), ampule of 1 mL, 1.0 mg/mL in methanol (as free base), certified reference material |
| Methylphenidate hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| METHYLPHENIDATE HYDROCHLORIDE(SEE ALSO: METHYLPHENIDATE, CAS 113-45-1, NTPNO M20344) |
| Methylphenidate.HCl |
| Methylphenidate(Ritalin) |
| Methylphenidylacetate hydrochloride |
| Metilfenidat hydrochloride |
| MFCD00058191 |
| MLS003922100 |
| NCGC00091942-01 |
| NCGC00257863-01 |
| NSC 169868 |
| NSC-169868 |
| NSC-759278 |
| NSC169868 |
| NSC759278 |
| Pharmakon1600-01505907 |
| QuilliChew ER |
| Quillivant XR |
| Quillivant xr (TN) |
| Rilaline |
| Rilatine |
| Ritalin |
| Ritalin (TN) |
| Ritalin hy drochloride |
| Ritalin hydrochloride |
| Ritalin SR |
| Ritalin-SR |
| SC-83308 |
| SCHEMBL41067 |
| SMR000058998 |
| threo-Methyl |A-phenyl-|A-(2-piperidyl)acetate hydrochloride |
| Tox21_111186 |
| Tox21_200309 |
| TRANSGENIC MODEL EVALUATION (METHYLPHENIDATE HYDROCHLORIDE) (SEE ALSO: METHYLPHENIDATE HYDROCHLORIDE) |
| WLN: T6MTJ BYR & VO1 & GH |
US Patents and Regulatory Information for RITALIN LA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-004 | Apr 10, 2004 | AB1 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-003 | Jun 5, 2002 | AB1 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-001 | Jun 5, 2002 | AB1 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-002 | Jun 5, 2002 | AB1 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | ||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for RITALIN LA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-001 | Jun 5, 2002 | ➤ Sign Up | ➤ Sign Up |
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-004 | Apr 10, 2004 | ➤ Sign Up | ➤ Sign Up |
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-002 | Jun 5, 2002 | ➤ Sign Up | ➤ Sign Up |
| Novartis | RITALIN LA | methylphenidate hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 021284-002 | Jun 5, 2002 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Paragraph IV (Patent) Challenges for RITALIN LA
| Drugname | Dosage | Strength | RLD | Date |
|---|---|---|---|---|
| ➤ Subscribe | Extended-release Capsules | 10 mg | ➤ Subscribe | ➤ Sign Up |
| ➤ Subscribe | Extended-release Capsules | 20 mg, 30 mg and 40 mg | ➤ Subscribe | ➤ Sign Up |
International Patents for RITALIN LA
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2007150075 | ➤ Sign Up |
| Australia | 2009201786 | ➤ Sign Up |
| Canada | 2348871 | ➤ Sign Up |
| Australia | 2007260822 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
